Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-51594
Mar Drugs 2023 Jan 31;212:. doi: 10.3390/md21020101.
Show Gene links Show Anatomy links

New Nostocyclophanes from Nostoc linckia.

Dai J , Philbin CS , Wakano C , Yoshida WY , Williams PG .


???displayArticle.abstract???
Six new nostocyclophanes and four known compounds have been isolated from Nostoc linckia (Nostocaceae) cyanobacterial strain UTEX B1932. The new compounds, nostocyclophanes E-J (1-6), were characterized by NMR and MS techniques. The known compounds were nostocyclophanes B-D, previously isolated from this strain, and dedichloronostocyclophane D. Structural modifications on the new [7.7]paracyclophane analogs 1-5, isolated from the 80% methanol fraction, range from simple changes such as the lack of methylation or halogenation to more unusual modifications such as those seen in nostocyclophane H (4), in which the exocyclic alkyl chains are of different length; this is the first time this modification has been observed in this family of natural products. In addition, nostocyclophane J (6) is a linear analog in which C-20 is chlorinated in preparation for the presumed enzymatic Friedel-Craft cyclization needed to form the final ring structure, analogous to the biosynthesis of the related cylindrocyclophanes. Nostocyclophane D, dedichloronostocyclophane D, and nostocyclophanes E-J demonstrated moderate to weak growth inhibition against MDA-MB-231 breast cancer cells.

???displayArticle.pubmedLink??? 36827142
???displayArticle.link??? Mar Drugs
???displayArticle.grants??? [+]


References [+] :
Braffman, Structural basis for an unprecedented enzymatic alkylation in cylindrocyclophane biosynthesis. 2022, Pubmed